Clinical trial · Interventional
Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy
NCT05861362CI-TRIAL-00066462completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The intervention consists of the adoption of a 5:2 intermittent fasting diet during radiotherapy of breast cancer patients. The aim of the study was to assess the feasibility of this intervention and its impact on body composition and selected metabolic blood parameters.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 5:2 intermittent fasting | Behavioral | — | UNRESOLVED |
| Curative radiotherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- FAST
- description
- 5:2 intermittent fasting group
- interventionNames
- Radiation: Curative radiotherapy
- Behavioral: 5:2 intermittent fasting
Primary outcomes (6)
- measure
- Dropout rate in the FAST intervention group
- timeFrame
- Through study completion, an average of 5 weeks
- description
- Used to measure feasibility. The intervention is rated as feasible if dropout rate is \<30%
- measure
- Longitudinal changes in body mass
- timeFrame
- Through study completion, an average of 5 weeks
- description
- Body mass (in kg) is measured by a bioimpedance device with an integrated scale (seca mBCA, seca Deutschland, Hamburg, Germany).
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Non-metastasized breast cancer * Indication for curative radiotherapy Exclusion Criteria: * metallic body parts that would interfere with electric bioimpedance (BIA) measurements * difficulties with understanding the aims of the study
References
Publications (0)
Data not yet available
No reference posted for this study.